Buzz Stocks: Walgreens Boots Alliance Inc, Medivation Inc, and Tesla Motors Inc

Today's stocks to watch in the news include Walgreens Boots Alliance Inc (NASDAQ:WBA), Medivation Inc (NASDAQ:MDVN), and Tesla Motors Inc (NASDAQ:TSLA)

by Celeste Taylor

Published on Jul 6, 2016 at 10:13 AM

U.S. stocks are down as investors flee amid renewed "Brexit" concerns. Among equities in focus are pharmacy retailer Walgreens Boots Alliance Inc (NASDAQ:WBA), biotech Medivation Inc (NASDAQ:MDVN), and electric auto stock Tesla Motors Inc (NASDAQ:TSLA).

  • WBA is down 2.2% at $81.66, as the firm's fiscal third-quarter revenue miss overshadows a per-share earnings beat and upwardly revised guidance. Walgreens Boots Alliance Inc CEO Stefano Pessina acknowledged the the "period of uncertainty" following the Brexit vote "will be quite long," and said the company is very confident that its deal with Rite Aid Corporation (NYSE:RAD) will go through. WBA has managed to claw its way back from its annual low in February, but is still down more than 4% year-to-date, with rebound attempts capped at its 320-day moving average. Analysts seem optimistic towards the stock, however, with 11 of 15 rating Walgreens Boots Alliance Inc a "buy" or better, and without a single "sell" rating to be found.
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Huge New Legal Marijuana Market Has Shortage Crisis
250 million Europeans have access to medical marijuana. There's already a shortage....
ZUMZ Stumbles Despite Post-Earnings Praise
Zumiez reported first-quarter losses and revenue that missed analysts' estimates
J M Smucker Stock Jammed by Ugly Sales Outlook
J M Smucker's fourth-quarter profits and revenue were better than Wall Street expected
The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.